The US Food and Drug Administration's (FDA’s) Center for Biologics Evaluation and Research (CBER) is refusing to review Moderna’s application for approval of a new flu vaccine. The decision comes ...
In a study published today in The New England Journal of Medicine, Greinacher and his colleagues show that the first theory ...
Finally, it's the Mazda CX-5's turn! The automaker's best-selling vehicle in the U.S. is all-new for 2026. While its looks ...